Recent advances in the treatment of type 1 diabetes mellitus

被引:4
|
作者
Schloot, N. C. [1 ,2 ]
Roden, M. [1 ,2 ]
Bornstein, S. R. [3 ,4 ,5 ]
Brendel, M. D. [3 ,4 ,5 ]
机构
[1] Univ Dusseldorf, Inst Klin Diabetol, Deutsch Diabet Zentrum, Leibniz Zentrum Diabet Forsch, D-4000 Dusseldorf, Germany
[2] Univ Klinikum Dusseldorf, Klin Stoffwechselkrankheiten, Dusseldorf, Germany
[3] Carl Gustav Carus Univ, Med Klin & Poliklin 3, Univ Klinikum Dresden, Dresden, Germany
[4] Tech Univ Dresden, Paul Langerhans Inst Diabet Forsch, Dresden, Germany
[5] Ctr Regenerat Therapies, Dresden, Germany
关键词
type; 1; diabetes; immunoprevention; islet transplantation; pancreas transplantation; BETA-CELL FUNCTION; ISLET TRANSPLANTATION; DOUBLE-BLIND; INSULIN; INTERVENTION; SURVIVAL; PANCREAS; THERAPY; DISEASE; TRIAL;
D O I
10.1055/s-0031-1272502
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interventional approaches to beta cell preservation: In a pilot study, initial attempts at primary prevention by preserving islet beta cells have been successful with highly hydrolyzed milk formula in children who are at high genetic risk of diabetes. Attempts at secondary prevention by intranasal application in children with a high-risk HLA genotype and positive islet autoantibodies have been disappointing. But in tertiary prevention anti-inflammatory, antigen-directed and T-cell targeted treatment has been partially successful in slowing down the destruction of beta cells. Biological beta cell substitution: Transplantation of a vascularised pancreas or islet cells results in disease regression and the prevention of secondary/tertiary complications of diabetes. A principal aim is the avoidance of frequent, severe hypoglycaemic episodes resulting from markedly reduced awareness of hypoglycaemia or its counter-regulation. © Georg Thieme Verlag KG Stuttgart New York.
引用
收藏
页码:172 / 175
页数:4
相关论文
共 50 条
  • [31] Type 1 Diabetes Mellitus: A Review on Advances and Challenges in Creating Insulin Producing Devices
    Oliveira, Sonia M. Rodrigues M.
    Rebocho, Antonio
    Ahmadpour, Ehsan
    Nissapatorn, Veeranoot
    Pereira, Maria de Lourdes
    MICROMACHINES, 2023, 14 (01)
  • [32] Immunotherapy Strategies for the Prevention and Treatment of Distinct Stages of Type 1 Diabetes: An Overview
    Rapini, Novella
    Schiaffini, Riccardo
    Fierabracci, Alessandra
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (06)
  • [33] Islet (cell) transplantation for type 1 diabetes mellitus
    Schmid, J.
    Ludwig, B.
    Brendel, M. D.
    DIABETOLOGE, 2011, 7 (08): : 585 - +
  • [34] In light of recent clinical trial results, what lies next for Type 1 diabetes vaccine research?
    Ludvigsson, Johnny
    EXPERT REVIEW OF VACCINES, 2012, 11 (03) : 263 - 265
  • [35] The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes
    Coppieters, Ken
    von Herrath, Matthias
    FRONTIERS IN MEDICINE, 2018, 5
  • [36] Adipose Tissue, Hormones, and Treatment of Type 1 Diabetes
    Gunawardana, Subhadra C.
    CURRENT DIABETES REPORTS, 2012, 12 (05) : 542 - 550
  • [37] Arresting type 1 diabetes: are we there yet? Obstacles and opportunities
    Mathieu, Chantal
    Martens, Pieter-Jan
    METABOLISM AND TARGET ORGAN DAMAGE, 2022, 2 (04):
  • [38] Recent developments in the discovery of FFA1 receptor agonists as novel oral treatment for type 2 diabetes mellitus
    Defossa, Elisabeth
    Wagner, Michael
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (14) : 2991 - 3000
  • [39] Recent research trend in cell and drug delivery system for type 1 diabetes treatment
    Im G.-B.
    Bhang S.H.
    Journal of Pharmaceutical Investigation, 2018, 48 (2) : 175 - 185
  • [40] Novel approaches to the treatment of hyperglycaemia in type 2 diabetes mellitus
    Galligan, A.
    Greenaway, T. M.
    INTERNAL MEDICINE JOURNAL, 2016, 46 (05) : 540 - 549